Founded in 1976, Genentech is a pioneering biotechnology company that discovers, develops, and manufactures medicines for serious medical conditions. Its targeted therapies treat cancer, autoimmune disorders, and eye diseases. Patients benefit from innovative treatments like Avastin and Rituxan, while healthcare providers gain advanced options to improve outcomes. A Roche subsidiary, it remains a global leader in translating science into life-saving drugs.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends